R. Kirk Huntsman, Director, Vivos Therapeutics
A good night’s sleep, one of the key essentials for a healthy human body, is a rare luxury these days. With fast-paced careers, long commutes, active lifestyles and an excessive reliance on technology, sleep disorders are taking a toll on our circadian cycle. According to a recent study conducted by the American Sleep Association (ASA), 50-70 million people in the U.S suffer from various sleep disorders, with Obstructive Sleep Apnea (OSA) being one of the more prevalent conditions, accounting for close to 25 million adult cases. OSA is a disorder that causes breathing to repeatedly stop and start during sleep and can be the root of many chronic diseases if left unmanaged, resulting in a host of physical ailments and potentially fatal outcomes if left untreated. Up to now, treatment for those suffering from OSA has been arduous, involving a significant amount of invasive procedures and lifelong interventions, all while the condition progressively worsens with minimal chance of recovery. Cue Dr. David Singh, Kirk Huntsman, and Vivos Therapeutics, Inc.
In Dr. Singh’s research, and among his peers, it has been observed that masticatory actions have significantly decreased due to the consumption of soft, easy to chew foods. Additionally, we no longer breast feed for extended periods of time, if at all. Therefore, our jaws remain underdeveloped when compared to our ancestors.
The underdevelopment of our upper and lower jaws contributes to a narrow airway, which then contributes to mouth breathing, sleep disordered breathing and OSA. Nasal breathing, which produces nitric oxide, is essential for achieving restorative sleep. Further, as we age, our airway tissues can start collapsing during sleep, causing our breathing to stop and start multiple times. There has never been an effective solution to treat sleep apnea, only palliative implements, including mechanical solutions that forced patients to wear masks while sleeping. These methods were not permanent solutions as they could only treat the symptoms of OSA, never addressing the root cause.
Vivos designed a potential permanent solution to the OSA epidemic in contrast to the continuous positive air pressure (CPAP) devices that force the patient to lifelong use of devices with limited effectiveness
But The Vivos System—using the pioneering work of Dr. Dave Singh—can be a lasting solution to the condition. “Vivos designed a potential permanent solution to the OSA epidemic in contrast to the continuous positive air pressure (CPAP) devices that force the patient to lifelong use with limited effectiveness,” states Kirk Huntsman, CEO, Vivos Therapeutics.
We believe, the Vivos System harnesses the body’s own temporal spatial patterning that is built into human DNA and uses the forces of epigenetics to activate and remodel the human tissues. Harnessing the body’s own genetic coding to stimulate remodelling of the upper and lower jaw, while training the tongue to be forward and against the roof of the mouth, the airway is expanded. These more open airways allow air to flow freely into the pharynx which facilitates regular nocturnal breathing without interruption, or obstruction.
Starting with a consultation from a trained dentist, patients are thoroughly screened and evaluated, and a home sleep test or in lab sleep test is conducted. Working with a board certified sleep medicine doctor, the sleep test helps the doctor to identify breathing patterns and give diagnosis for patient’s condition. Based on a medical diagnosis, further screening may take place, to identify where the obstructions are and what kind of treatment approach needs to be taken. A custom-made oral appliance may be created, with specific instructions on use. After an average of twelve to eighteen months of use, improved sleep patterns have been observed by the both dentists and users. These include improvement of mild-to-moderate, snoring, and sleep disordered breathing in people of all ages.
The Vivos System offers the potential for a lasting solution and does so non-surgically, noninvasively and non-pharmaceutically. Vivos Therapeutics, Inc is gradually building its Integrated Network of Providers in North America and will move to international expansion opportunities in 2020. The company is underway to bring about a massive revolution in the market space. For Vivos, this method is not only a technology but a movement toward wellness, health, and vitality.